Dabigatran Etexilate Capsules Recalled Over Impurity Specification Failure
Ascend Laboratories is recalling dabigatran etexilate capsules due to an out-of-specification result in related substance testing involving Impurity II, Impurity III, and total impurities observed during 12-month stability testing.
- Product
- DABIGATRAN ETEXILATE — DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE)
- Category
- Drug
- Distribution
- Distributed nationwide